André Raposo Moreira Dias took his BSc degree in Biochemistry (Jul 2011) at New University of Lisbon (final grade 15/20). After receiving his MSc in Medicinal Chemistry (Dec 2013) from Faculty of Pharmacy – University of Lisbon (final grade 17/20) and his PhD in Chemistry (Sep 2018) from University of Milano (Italy) the candidate joined Prof. Pedro Gois’ group for postdoctoral studies (Oct 2018) in a bioorganic chemistry research project (supported by FCT). The candidate began his research career in 2013 during his MSc thesis where he integrated the group of Prof. Rui Moreira (FFUL) on the “Development of chemical tools to study the mechanism of action of new 4-aminoquinazolines as inhibitors of malaria liver stage”. Later on, the candidate worked with Dr. Ana Ressurreição (Prof. Rui Moreira’s group) in a MSc fellowship awarded by FCT (2014-2015, carrying on MSc project): “Bioorthogonal clickable probes to target the liver stage of malaria”. From this period, resulted a publication in a book chapter (book of organic chemistry experiments for the laboratory classroom that was published by the Royal Society of Chemistry in 2016) and another paper is being built up. In June 2015, the candidate moved to Milano where he started his PhD fellowship supervised by Prof. Cesare Gennari (University of Milano, Italy) and Prof. Norbert Sewald (University of Bielefeld, Germany) in a Marie Sklodowska-Curie ITN fellowship called MAGICBULLET. During his PhD, the candidate worked on cancer therapy field in the synthesis of Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy (one project in collaboration with Bayer AG, Germany). The candidate developed new RDG-Drug conjugates with high affinity for avß3 integrin (overexpressed receptor in tumors). During his academic secondment (Oct 2016-Apr 2017) in Bielefeld (Germany), the candidate worked on the synthesis of new anticancer agents bearing cryptophycin as cytotoxic drug. Moreover, the candidate joined Italfarmaco SpA (Italy) industry for a 3-month (Jan 2018-Mar 2018) secondment supervised by Dr. Christian Steinkühler on the synthesis of RGD-Auristatin conjugates for targeted delivery in tumors. The candidate published 2 first-author papers in Chem. Eur. J. and 1 co-author in Eur. J. Org. Chem. By now, 2 additional papers are being submitted related with the work done in both secondments. During his PhD period, the candidate supervised one undergraduate student and was awarded with two best poster prizes in two international conferences “Rimini Peptides Conference 2018” / “Bologna Peptides Conference 2016”. Moreover, the candidate gave one oral communication in an italian meeting dedicated to the latest findings by the young researchers (NEXT STEP EVENT 2016, Milano) and several presentations within the ITN network meetings. Currently, the candidate is based in Lisbon where he is starting his postdoctoral research on stimulus responsive click chemistry: the first triggerable tetrazine ligation”. In his curriculum Ciência Vitae the most frequent terms in the context of scientific, technological and artistic-cultural output are: Malária; Tumor Targeting; Selectivity; 4-aminoquinazolines; SAR; Medicinal Chemistry; Small molecule-drug conjugates; Cancer; RGD and Integrins.